Transformation Research: Neurodegenerative Diseases of Aging

NEW for 2018

 

  1. Translational research using humans or human samples/data is in scope, except for clinical trials or clinical trial sub-studies which should be submitted to the Early-Phase Clinical Trials or Rapid Response programs.
  2. The Institute has updated which tools are in scope. Please see below and read our What We Fund webpage before applying to ensure your project is in scope.

 

Goal

 

                                           

To provide funding for translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.

Funding 

A maximum of $1,500,000 over up to 3 years.

Applicant Eligibility

Eligible Principal Applicants must be researchers working in Canada at least 30% of the time at or above the level of Assistant Professor or equivalent, and be affiliated with a Canada Revenue Agency-qualified donee institution located in Canada. Co-Applicants/Collaborators must be at the post-doctoral level or above and can be working outside Canada.

Project Eligibility

Projects must meet the following conditions to be eligible:

  1. Be translational research, excluding clinical trials and clinical trial sub-studies, that accelerates the development of therapeutics for neurodegenerative diseases of aging.
  • Clinical trials and clinical trial sub-studies should be submitted to the Early-Phase Clinical Trials or Rapid Response programs; however other translational research using humans or human samples/data is in scope.
  1. Be the development of a therapeutic and/or tool.
  2. Have excellent preliminary data to support the proposed project.

Disease scope:

All the Institute’s neurodegenerative diseases of aging are covered by this program (see What We Fund page).

 

Development scope:

Development of a therapeutic and/or a tool that helps to accelerate the development of therapeutics for neurodegenerative diseases of aging.

 

Important Dates

Program Information Webinar:

October 25th, 2017 at 1pm EDT (Register here)

Letter of Intent Deadline:

December 7th, 2017 at 2pm EDT

Anticipated Award:

August 2018

APPLY HERE

 
Agency Name: 
Weston Brain Institute
Contact Name: 
Penny D'Agnone
Grant Amount: 
$1,500,000 over 3 years
Grant Location: 
External
External Deadline: 
Thursday, December 7, 2017
Grant Type: 
Research
Grant Area: 
Health
Grant Eligibility: 
Faculty